Picture of Precigen logo

PGEN — Precigen News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Precigen Inc expected to post a loss of 8 cents a share - Earnings Preview

* Precigen Inc  PGEN.OQ   PGEN.O  is expected to show a fall
in
quarterly revenue when it reports  results on March 19 for the
period ending December 31 2023
    * The Germantown Maryland-based  company is expected to
report a
3.6% decrease in revenue to $1.7 million from $1.76 million a
year ago, according to the mean estimate from 4 analysts, based
on LSEG data.
    * ​LSEG's mean analyst estimate for Precigen Inc is for a
loss
of 8 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Precigen
Inc is
$7.00​, above​ its last closing price of $1.43. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  -0.08       -0.08      -0.08     Met     -2.6
 Jun. 30 2023  -0.10       -0.10      -0.08     Beat    20
 Mar. 31 2023  -0.10       -0.09      -0.10     Missed  -9.6​
 Dec. 31 2022  -0.10       -0.10      -0.11     Missed  -10
 ​​Sep.        0.00        0.02       -0.04     Missed  -340
 30 2022                                                
 Jun. 30 2022  -0.15       -0.13      -0.09     Beat    31.8​
 Mar. 31 2022  -0.14       -0.13      -0.10     Beat    21.6
 Dec. 31 2021  -0.14       -0.14      -0.13     Beat    4.4
 This summary was machine generated March 15 at 21:10 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Precigen

See all news